8,265
Views
85
CrossRef citations to date
0
Altmetric
Research Paper/Report

Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner

&
Pages 421-432 | Received 07 Nov 2018, Accepted 29 May 2019, Published online: 16 Jun 2019

References

  • Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
  • Rosen DS. Pubertal growth and sexual maturation for adolescents with chronic illness or disability. Pediatrician. 1991;18:105–120.
  • Brain CE, Savage MO. Growth and puberty in chronic inflammatory bowel disease. Baillieres Clin Gastroenterol. 1994;8:83–100.
  • Rigaud D, Angel LA, Cerf M, Carduner MJ, Melchior JC, Sautier C, René E, Apfelbaum M, Mignon M. Mechanisms of decreased food intake during weight loss in adult Crohn’s disease patients without obvious malabsorption. Am J Clin Nutr. 1994;60(5):775–781. doi:10.1093/ajcn/60.5.775.
  • Andersen NN, Jess T. Risk of cardiovascular disease in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2014;5(3):359–365. doi:10.4291/wjgp.v5.i3.359.
  • von der Weid PY, Rehal S, Ferraz JG. Role of the lymphatic system in the pathogenesis of Crohn’s disease. Curr Opin Gastroenterol. 2011;27(4):335–341. doi:10.1097/MOG.0b013e3283476e8f.
  • Ge Y, Li Y, Gong J, Zhu W. Mesenteric organ lymphatics and inflammatory bowel disease. Ann Anat. 2018;218:199–204. doi:10.1016/j.aanat.2018.03.006.
  • Li Y, Zhu W, Zuo L, Shen B. The Role of the Mesentery in Crohn’s Disease: the Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course. Inflamm Bowel Dis. 2016;22(6):1483–1495. doi:10.1097/MIB.0000000000000791.
  • Lissner D, Sonnenberg E, Siegmund B. [Inflammatory bowel disease: cardinal signs and their diagnostics]. Dtsch Med Wochenschr. 2018;113(13):937–944. doi:10.1055/a-0612-3564.
  • Adams SM, Bornemann PH. Ulcerative colitis. Am Fam Physician. 2013;87:699–705.
  • Halfvarson J, Bodin L, Tysk C, Lindberg E, Järnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767–1773.
  • Orholm M, Binder V, Sørensen TIA, Rasmussen LP, Kyvik KO. Concordance of Inflammatory Bowel Disease among Danish Twins: results of a Nationwide Study. Scand J Gastroenterol. 2000;35:1075–1081.
  • Rezapour M, Galoosian A, Liu B, Bhuket T, Wong RJ. Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality. Eur J Gastroenterol Hepatol. 2018;30(9):1041–1046. doi:10.1097/MEG.0000000000001185.
  • McKay DM, Perdue MH. Intestinal epithelial function: the case for immunophysiological regulation. Implications for disease (2). Dig Dis Sci. 1993;38:1735–1745.
  • Gassler N, Newrzella D, Böhm C, Lyer S, Li L, Sorgenfrei O, van Laer L, Sido B, Mollenhauer J, Poustka A, et al. Molecular characterisation of non‐absorptive and absorptive enterocytes in human small intestine. Gut. 2006;55(8):1084–1089. doi:10.1136/gut.2005.073262.
  • Latorre R, Sternini C, De Giorgio R, Greenwood-Van Meerveld B. Enteroendocrine Cells: A Review of Their Role In Brain-Gut Communication. Neurogastroenterol Motil. 2016;28(5):620–630. doi:10.1111/nmo.12754.
  • Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol. 2011;9(5):356–368. doi:10.1038/nrmicro2546.
  • Metzger RN, Krug AB, Eisenächer K. Enteric Virome Sensing—its Role in Intestinal Homeostasis and Immunity. Viruses. 2018;10(4):146. doi:10.3390/v10040146.
  • Rhee SH. Basic and Translational Understandings of Microbial Recognition by Toll-Like Receptors in the Intestine. J Neurogastroenterol Motil. 2011;17(1):28–34. doi:10.5056/jnm.2011.17.1.28.
  • Yu S, Gao N. Compartmentalizing Intestinal Epithelial Cell Toll-like Receptors for Immune Surveillance. Cell Mol Life Sci. 2015;72(17):3343–3353. doi:10.1007/s00018-015-1931-1.
  • Chaturvedi A, Pierce SK. How location governs Toll like receptor signaling. Traffic. 2009;10(6):621–628. doi:10.1111/j.1600-0854.2009.00899.x.
  • Kawasaki T, Kawai T. Toll-Like Receptor Signaling Pathways. Front Immunol. 2014;5:461. doi:10.3389/fimmu.2014.00461.
  • Hindi SM, Kumar A. Toll-like receptor signalling in regenerative myogenesis: friend and foe. J Pathol. 2016;239(2):125–128. doi:10.1002/path.4714.
  • Huebener P, Schwabe RF. Regulation of Wound Healing and Organ Fibrosis by Toll-like Receptors. Biochim Biophys Acta. 2013;1832(7). doi:10.1016/j.bbadis.2012.11.017.
  • Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68(12):7010–7017. doi:10.1128/iai.68.12.7010-7017.2000.
  • Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide. J Immunol. 2001;167(3):1609. doi:10.4049/jimmunol.167.3.1609.
  • Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide Causes an Increase in Intestinal Tight Junction Permeability in Vitro and in Vivo by Inducing Enterocyte Membrane Expression and Localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375–387. doi:10.1016/j.ajpath.2012.10.014.
  • Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res. 2015;2015:489821. doi:10.1155/2015/489821.
  • Ngkelo A, Lewkowich IP, Zhou P, Ledford JR, Page K. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signalling. J Inflamm. 2012;9(1):1. doi:10.1186/1476-9255-9-32.
  • Tough DF, Sun S, Sprent J. T Cell Stimulation In Vivo by Lipopolysaccharide (LPS). J Exp Med. 1997;185(12):2089–2094. doi:10.1084/jem.185.12.2089.
  • Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–1499. doi:10.1053/j.gastro.2014.02.009.
  • Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145–151. doi:10.1016/j.cyto.2008.01.006.
  • Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. doi:10.1038/sigtrans.2017.23.
  • Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1. doi:10.1136/gut.53.1.1.
  • Terajima J, Iyoda S, Ohnishi M, Watanabe H. Shiga Toxin (Verotoxin)-Producing Escherichia coli in Japan. Microbiol Spectr. 2014;2(5). doi:10.1128/microbiolspec.EHEC-0011-2013.
  • Zhang S, Kingsley RA, Santos RL, Andrews-Polymenis H, Raffatellu M, Figueiredo J, Nunes J, Tsolis RM, Adams LG, Bäumler AJ. Molecular Pathogenesis of Salmonella enterica Serotype Typhimurium-Induced Diarrhea. Infect Immun. 2003;71(1):1–12. doi:10.1128/iai.71.1.1-12.2003.
  • Brien CL, Pavli P, Gordon DM, Allison GE. Detection of bacterial DNA in lymph nodes of Crohn’s disease patients using high throughput sequencing. Gut. 2014;63(10):1596. doi:10.1136/gutjnl-2013-305320.
  • Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol. 1999;473:11–30.
  • Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. doi:10.1155/2015/628157.
  • Deitch EA. Gut-Origin sepsis; evolution of a concept. Surgeon. 2012;10(6):350–356. doi:10.1016/j.surge.2012.03.003.
  • Halfvarson J, Brislawn CJ, Lamendella R, Vázquez-Baeza Y, Walters WA, Bramer LM, D’Amato M, Bonfiglio F, McDonald D, Gonzalez A, et al. Dynamics of the human gut microbiome in Inflammatory Bowel Disease. Nat Microbiol. 2017;2:17004. doi:10.1038/nmicrobiol.2017.4.
  • Günzel D, Yu ASL. Claudins and the Modulation of Tight Junction Permeability. Physiol Rev. 2013;93(2):525–569. doi:10.1152/physrev.00019.2012.
  • van der Walle CF, Schmidt E. Chapter 9 - Modulation of the Intestinal Tight Junctions Using Bacterial Enterotoxins. In: Van Der Walle C, editor. Peptide and Protein Delivery. Boston (MA): Academic Press; 2011. p. 195–219.
  • Ochieng JB, Boisen N, Lindsay B, Santiago A, Ouma C, Ombok M, Fields B, Stine OC, Nataro JP. Serratia marcescens is injurious to intestinal epithelial cells. Gut Microbes. 2014;5(6):729–736. doi:10.4161/19490976.2014.972223.
  • Cheung CH, Moore EW, Prystowsky JB, Rege RV. TNFα stimulates mucus secretion in gallbladder epithelial cells. Gastroenterology. 1998;114:A1225.
  • Mac CM. The movements of bones and joints; the mechanical structure of articulating cartilage. J Bone Joint Surg Br. 1951;33b(2:251–257.
  • Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol Gastrointest Liver Physiol. 2004;286(3):G367–G376. doi:10.1152/ajpgi.00173.2003.
  • Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361. doi:10.1038/nrc2628.
  • Rutgeerts P, Van Assche G, Sandborn WJ, Wolf DC, Geboes K, Colombel J-F, Reinisch W, Kumar A, Lazar A, Camez A, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn’s disease: data from the EXTEND trial. Gastroenterology.2012;142(5):1102–1111.e2.doi:10.1053/j.gastro.2012.01.035.
  • Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. J Clin Invest. 2014;124(10):4212–4218. doi:10.1172/JCI72333.
  • Rehal S, von der Weid PY. TNFDeltaARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery. Am J Pathol. 2017;187(4):798–807. doi:10.1016/j.ajpath.2016.12.007.
  • Rehal S, Stephens M, Roizes S, Liao S, von der Weid P-Y. Acute small intestinal inflammation results in persistent lymphatic alterations. Am J Physiol Gastrointest Liver Physiol. 2017;314(3):G408–G417. doi:10.1152/ajpgi.00340.2017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.